Substance Use Disorders (SUD) Clinical Trial
Official title:
Substance-use Focused Screening and Brief Intervention as a Complement to Internet-based Psychiatric Treatment for Depression, Panic Disorder or Social Phobia: A Randomized Controlled Trial
Objectives: This study evaluates the efficacy of eScreen for internet psychiatry patients
treated for major depressive disorder, panic anxiety and social phobia. The eScreen brief
Internet intervention for problematic alcohol and drug use offers self-screening, in-depth
self-reporting, personalized feedback and treatment recommendations as well as an electronic
diary. Progress over time is shown in diagrams detailing consumption levels.
Method: This is a two-armed randomized controlled design, measuring outcomes in terms of
changes in problematic alcohol use up to one year after study recruitment. Participants with
problematic alcohol use (AUDIT >7 for men and >5 for women) and/or problematic drug use
(DUDIT > 1 for both men and women) are randomized into one of two groups: T1, eScreen
referral or Control group. Outcomes on alcohol and drug use as well as health-related
symptoms are assessed after 3, 6 and 12 months.
The hypothesis is that the group receiving the eScreen intervention will reduce their
alcohol/drug use to a larger extent than the control group at follow-up compared to the
baseline level.
This study evaluated the efficacy of eScreen for internet psychiatry patients treated for
major depressive disorder, panic anxiety and social phobia. The eScreen brief Internet
intervention for problematic alcohol and drug use offers self-screening, in-depth
self-reporting, personalized feedback and treatment recommendations as well as an electronic
diary. Progress over time is shown in diagrams detailing consumption levels. The design was a
two-armed randomized controlled design, measuring outcomes in terms of changes in problematic
alcohol use up to one year after study recruitment. Participants with problematic alcohol use
(AUDIT >7 for men and >5 for women) and/or problematic drug use (DUDIT > 1 for both men and
women) were randomized into one of two groups: T1, eScreen referral or Control group.
Outcomes on alcohol and drug use as well as health-related symptoms are assessed after 3, 6
and 12 months.
The hypothesis was that the group receiving the eScreen intervention would reduce their
alcohol/drug use to a larger extent than the control group at follow-up compared to the
baseline level. The results have not yet been analyzed due to technical issues. However,
qualitative interviews have been conducted with participants and our intention is to publish
the qualitative results in tandem with the quantitative results available.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04232878 -
A Single Ascending Dose Trial of CVL-936 in Healthy Subjects
|
Phase 1 |